BIO-TECHNE Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
BIO-TECHNE Corp (TECH) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $25.90 million as of 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2026-08-24
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $25.90M.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $80.20M.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $439.70M.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $386.70M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2026-06-30 | $25.90M 10-K · filed 2026-08-24 |
| 2025-06-30 | $80.20M 10-K · filed 2025-08-22 |
| 2024-06-30 | $439.70M 10-K · filed 2024-08-22 |
| 2023-06-30 | $386.70M 10-K · filed 2023-08-23 |
| 2022-06-30 | $387.30M 10-K · filed 2022-08-24 |
| 2021-06-30 | $571.30M 10-K · filed 2021-08-25 |
| 2020-06-30 | $236.80M 10-K · filed 2020-08-26 |
| 2019-06-30 | $161.00M 10-K/A · filed 2019-11-06 |
| 2018-06-30 | $3.80M 10-K · filed 2018-08-27 |
| 2017-06-30 | $29.10M 10-K · filed 2017-09-07 |
| 2016-06-30 | $22.10M 10-K · filed 2016-08-29 |
| 2015-06-30 | $14.10M 10-K · filed 2015-08-31 |
| 2014-06-30 | $12.30M 10-K · filed 2014-08-29 |
| 2013-06-30 | $2.60M 10-K · filed 2013-08-29 |
| 2012-09-30 | $3.90M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $4.70M 10-K · filed 2012-08-29 |
| 2012-03-31 | $3.30M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $2.90M 10-Q · filed 2012-02-07 |
| 2011-09-30 | $2.80M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $7.60M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |